Home › Funds › CAPITAL INTERNATIONAL LTD /CA/ › VRTX

CAPITAL INTERNATIONAL LTD /CA/ position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

CAPITAL INTERNATIONAL LTD /CA/ reported holding 100,051 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$52.3M, representing 1.68% of its reported portfolio and ranking #15 among its reported holdings. CAPITAL INTERNATIONAL LTD /CA/ has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)100.05K sh
Reported value held$52.31M
Portfolio Weight1.68%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CAPITAL INTERNATIONAL LTD /CA/'s VRTX position evolved

CAPITAL INTERNATIONAL LTD /CA/ first disclosed a stake in VRTX in Q3 2023 at 81,499 shares (US$28.3M). The position peaked in Q2 2025 at 127,607 shares, worth US$56.8M. Across 13 filings, CAPITAL INTERNATIONAL LTD /CA/ increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 100,051 shares valued at US$52.3M — an increase of 2,717 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 81.50K $28.34M New
Q4 2023 84.88K $34.54M Add
Q1 2024 99.56K $41.62M Add
Q2 2024 100.47K $47.09M Add
Q3 2024 99.61K $46.32M Reduce
Q4 2024 110.57K $44.53M Add
Q1 2025 112.55K $54.56M Add
Q2 2025 127.61K $56.81M Add
Q3 2025 121.29K $47.50M Reduce
Q4 2025 95.61K $43.35M Reduce
Q1 2026 95.87K $42.81M Hold
Q2 2026 97.33K $48.35M Add
Q3 2026 100.05K $52.31M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has CAPITAL INTERNATIONAL LTD /CA/ held VRTX?

CAPITAL INTERNATIONAL LTD /CA/ has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CAPITAL INTERNATIONAL LTD /CA/'s current position in VRTX?

As of Q3 2026, CAPITAL INTERNATIONAL LTD /CA/ holds 100.05K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $52.31M, representing 1.68% of its reported portfolio and ranking #15.

Has CAPITAL INTERNATIONAL LTD /CA/ been buying or selling VRTX?

In the latest 13F filing (Q3 2026), CAPITAL INTERNATIONAL LTD /CA/ increased its position in VRTX. The position peaked in Q2 2025 at 127.61K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.